Early relapse risk after a first CNS inflammatory demyelination episode: Examining international consensus definitions

Developmental Medicine and Child Neurology

Volumn 49, Issue 12, 2007, Pages 887-893

  Dale, Russell C ^a,b   Pillai, Sekhar C ^b  

^a University of Sydney   (Australia)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

OLIGOCLONAL BAND;

ACUTE DISEASE; ADOLESCENT; ARTICLE; CHILD; CONSENSUS DEVELOPMENT; DEMYELINATING DISEASE; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DISEASE CLASSIFICATION; ENCEPHALOMYELITIS; FEMALE; FOLLOW UP; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HUMAN; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

ADOLESCENT; BRAIN; CHILD; CHILD, PRESCHOOL; CONSENSUS; DEMYELINATING DISEASES; DIAGNOSIS, DIFFERENTIAL; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMANS; INFANT; INTERNATIONAL COOPERATION; MAGNETIC RESONANCE IMAGING; MALE; MULTIPLE SCLEROSIS; MYELIN SHEATH; RECURRENCE; RISK FACTORS; TIME FACTORS;

EID: 36549080166     PISSN: 00121622     EISSN: 14698749     Source Type: Journal    
DOI: 10.1111/j.1469-8749.2007.00887.x     Document Type: Article

References (21)

1. Krupp LB, Banwell B, Tenembaum S; International Pediatric Multiple Sclerosis Study Group (2007) Consensus definitions proposed for pediatric multiple sclerosis and related disorders. Neurology 68(16 Suppl. 2): S7-12.
2. Tenembaum S, Chitnis T, Ness J, Hahn JS; International Pediatric Multiple Sclerosis Study Group (2007) Acute disseminated encephalomyelitis. Neurology 68(16 Suppl. 2): S23-36.
3. Mikaeloff Y, Caridade G, Husson B, Suissa S, Tardieu M; on behalf of the Neuropediatric KIDSEP Study Group of the French Neuropediatric Society (2007) Acute disseminated encephalomyelitis cohort study: Prognostic factors for relapse. Eur J Paediatr Neurol 11: 90-95.
4. Dale RC, de Sousa C, Chong WK, Cox TC, Harding B, Neville BG. (2000) Acute disseminated encephalomyelitis, multiphasic disseminated encephalomyelitis and multiple sclerosis in children. Brain 123: 2407-2422.
5. Tenembaum S, Chamoles N, Fejerman N. (2002) Acute disseminated encephalomyelitis: A long-term follow-up study of 84 pediatric patients. Neurology 59: 1224-1231.
6. Hynson JL, Kornberg AJ, Coleman LT, Shield L, Harvey AS, Kean MJ. (2001) Clinical and neuroradiologic features of acute disseminated encephalomyelitis in children. Neurology 56: 1308-1312.
7. Mikaeloff Y, Suissa S, Vallee L, Lubetzki C, Ponsot G, Confavreux C, Tardieu M; KIDMUS Study Group (2004) First episode of acute CNS inflammatory demyelination in childhood: Prognostic factors for multiple sclerosis and disability. J Pediatr 144: 246-252.
8. Pohl D, Hennemuth I, von Kries R, Hanefeld F. (2007) Paediatric multiple sclerosis and acute disseminated encephalomyelitis in Germany: Results of a nationwide survey. Eur J Pediatr 166: 405-412.
9. Belman AL, Chitnis T, Renoux C, Waubant E; International Pediatric Multiple Sclerosis Study Group (2007) Challenges in the classification of pediatric multiple sclerosis and future directions. Neurology 68(16 Suppl. 2): S70-74. p S71.
10. Pohl D, Rostasy K, Gartner J, Hanefeld F. (2005) Treatment of early onset multiple sclerosis with subcutaneous interferon beta-1a. Neurology 64: 888-890.
11. Tenembaum SN, Segura MJ. (2006) Interferon beta-1a treatment in childhood and juvenile-onset multiple sclerosis. Neurology 67: 511-513.
12. Banwell B, Reder AT, Krupp L, Tenembaum S, Eraksoy M, Alexey B, Pohl D, Freedman M, Schelensky L, Antonijevic I. (2006) Safety and tolerability of interferon beta-1b in pediatric multiple sclerosis. Neurology 66: 472-476.
13. Ghezzi A, Amato M P, Capobianco M, Gallo P, Marrosu G, Martinelli V, Milani N, Milanese C, Moiola L, Patti F, et al. (2005) Disease-modifying drugs in childhood-juvenile multiple sclerosis: Results of an Italian co-operative study. Mult Scler 11: 420-424.
14. Ness JM, Chabas D, Sadovnick AD, Pohl D, Banwell B, Weinstock-Guttman B; International Pediatric Multiple Sclerosis Study Group (2007) Clinical features of children and adolescents with multiple sclerosis. Neurology 68 (16 Suppl. 2): S37-45.
15. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, McFarland HF, Paty DW, Polman CH, Reingold SC, et al. (2001) Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50: 121-127.
16. Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Lublin FD, Metz LM, McFarland HF, O'Connor P W, et al. (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol 58: 840-846.
17. Hahn CD, Shroff MM, Blaser SI, Banwell BL. (2004) MRI criteria for multiple sclerosis: Evaluation in a pediatric cohort. Neurology 62: 806-808.
18. Banwell B, Shroff M, Ness JM, Jeffery D, Schwid S, Weinstock-Guttman B; International Pediatric Multiple Sclerosis Study Group (2007) MRI features of pediatric multiple sclerosis. Neurology 68(16 Suppl. 2): S46-53.
19. Mikaeloff Y, Adamsbaum C, Husson B, Vallee L, Ponsot G, Confavreux C, Tardieu M, Suissa S; KIDMUS Study Group on Radiology (2004) MRI prognostic factors for relapse after acute CNS inflammatory demyelination in childhood. Brain 127: 1942-1947.
20. Banwell BL. (2004) Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 4: 245-252.
21. Pohl D, Rostasy K, Reiber H, Hanefeld F. (2004) CSF characteristics in early-onset multiple sclerosis. Neurology 63: 1966-1967.